PCRX
Pacira BioSciences, Inc.NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$918.77M
P/E Ratio
179.62
EPS
$0.13
Beta
0.32
52W High
$27.64
52W Low
$18.80
50-Day MA
$23.53
200-Day MA
$23.72
Dividend Yield
—
Profit Margin
0.70%
Forward P/E
8.02
PEG Ratio
11.21
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is headquartered in Parsippany, New Jersey.
Fundamentals
| Revenue (TTM) | $734.86M |
| Gross Profit (TTM) | $583.01M |
| EBITDA | $121.29M |
| Operating Margin | 2.61% |
| Return on Equity | 0.71% |
| Return on Assets | 1.35% |
| Revenue/Share (TTM) | $17.05 |
| Book Value | $16.63 |
| Price-to-Book | 1.41 |
| Price-to-Sales (TTM) | 1.25 |
| EV/Revenue | 1.542 |
| EV/EBITDA | 9.57 |
| Quarterly Earnings Growth (YoY) | -30.00% |
| Quarterly Revenue Growth (YoY) | 5.00% |
| Shares Outstanding | $39.35M |
| Float | $33.67M |
| % Insiders | 1.74% |
| % Institutions | 115.56% |
Historical Volatility
HV 10-Day
32.77%
HV 20-Day
36.74%
HV 30-Day
35.04%
HV 60-Day
35.38%
HV Rank
42.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($29.29 target)
1
Strong Buy3
Buy2
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026